Profil bibliographique

L. Bucci

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

192Publications signalées

4229Citations signalées

2Affiliations récentes

Institutions déclarées

Friedrich-Alexander-Universität Erlangen-Nürnberg Universitätsklinikum Erlangen

Domaines associés

Colorectal Cancer Surgical TreatmentsInflammatory Bowel DiseaseDiverticular Disease and ComplicationsColorectal and Anal CarcinomasGastric Cancer Management and Outcomes

Publications récentes

Accès ouvert 2025 conference-abstractOpenAlex

POS0798 B CELL RECONSTITUTION IN SLE PATIENTS AFTER CAR-T CELL THERAPY IS MARKED BY A NAÏVE PHENOTYPE AND REDUCTION OF EXTRAFOLLICULAR IMMUNE RESPONSES

Danae-Mona Nöthling, L. Bucci, T. Rothe, К. И. Аношкин et autres

0 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2025 conference-abstractOpenAlex

POS0946 IMMUNOCLEANSING-ASSOCIATED TOXICITY SYNDROME (ICATS) IN CAR T-CELL TREATED PATIENTS WITH AUTOIMMUNE DISEASE

Melanie Hagen, Fabian Müller, Andreas Wirsching, S. Kharboutli et autres

1 citationAnnals of the Rheumatic Diseases

Accès ouvert 2025 conference-abstractOpenAlex

POS0057 EFFECTS OF T CELL ENGAGERS TREATMENT ON B AND T CELLS IN AUTOIMMUNE DISEASE

L. Bucci, T. Rothe, К. И. Аношкин, Danae-Mona Nöthling et autres

3 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2025 conference-abstractOpenAlex

ABS0364 SAFETY AND EFFICACY OF T CELL ENGAGER THERAPY IN PATIENTS WITH REFRACTORY AUTOIMMUNE DISEASE

L. Bucci, S. Boeltz, Melanie Hagen, Danae-Mona Nöthling et autres

4 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2025 conference-abstractOpenAlex

POS0062 SAFETY AND PRELIMINARY EFFICACY OF CD19 CAR T-CELL TREATMENT IN RHEUMATIC DISEASE – DATA FROM THE PHASE I/II CASTLE BASKET STUDY

Melanie Hagen, Andreas Wirsching, Fabian Müller, Soraya Kharboutli et autres

4 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2025 articleOpenAlex

Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey

Andrea Balla, Federica Saraceno, Marika Rullo, Salvador Morales‐Conde et autres

4 citationsUpdates in Surgery

2024 conference-abstractOpenAlex

POS0340 EFFECTS OF CAR-T CELL TREATMENT ON B CELL IMMUNITY IN SYSTEMIC AUTOIMMUNE DISEASES

L. Bucci, T. Rothe, Fabian Müller, J. Taubmann et autres

1 citationAnnals of the Rheumatic Diseases

2024 conference-abstractOpenAlex

OP0027 LONG-TERM SAFETY AND EFFICACY OF CAR-T CELL TREATMENT IN SEVERE AND TREATMENT REFRACTORY AUTOIMMUNE DISEASE

J. Taubmann, Fabian Müller, Filippo Fagni, Christina Bergmann et autres

9 citationsAnnals of the Rheumatic Diseases

2024 conference-abstractOpenAlex

OP0320 EFFICACY OF CD19-TARGETING CAR T CELL TREATMENT IN PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS (dSSc) – AN OPEN LABEL, SINGLE-CENTER PILOT STUDY

J. Auth, Fabian Müller, J. Taubmann, Simon Völkl et autres

3 citationsAnnals of the Rheumatic Diseases

2024 conference-abstractOpenAlex

OP0193 BITEING MULTI-DRUG RESISTANT RHEUMATOID ARTHRITIS WITH CD19-T CELL ENGAGERS

L. Bucci, Melanie Hagen, T. Rothe, M. G. Raimondo et autres

2 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2024 articleOpenAlex

Development and external validation of the ‘Global Surgical-Site Infection’ (GloSSI) predictive model in adult patients undergoing gastrointestinal surgery

McLean KA, Knight SR, Nina M. Clark, Adesoji Ademuyiwa et autres

4 citationsBritish journal of surgery

Accès ouvert 2023 articleOpenAlex

Is it the Type of Axillary Surgery or the Number of Removed Lymph Nodes That Increases the Risk of Breast Cancer Related Lymphedema (BCRL)? Results from a Prospective Screening Trial

George E. Naoum, Brooke C. Juhel, Hazim Ababneh, Amy M. Shui et autres

3 citationsInternational Journal of Radiation Oncology*Biology*Physics

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.